[go: up one dir, main page]

DK1248638T3 - Use of enoxaparin for the treatment of cerebral ischemia - Google Patents

Use of enoxaparin for the treatment of cerebral ischemia

Info

Publication number
DK1248638T3
DK1248638T3 DK01903859T DK01903859T DK1248638T3 DK 1248638 T3 DK1248638 T3 DK 1248638T3 DK 01903859 T DK01903859 T DK 01903859T DK 01903859 T DK01903859 T DK 01903859T DK 1248638 T3 DK1248638 T3 DK 1248638T3
Authority
DK
Denmark
Prior art keywords
enoxaparin
treatment
cerebral ischemia
ischemia
cerebral
Prior art date
Application number
DK01903859T
Other languages
Danish (da)
Inventor
Veronique Mary
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1248638T3 publication Critical patent/DK1248638T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01903859T 2000-01-06 2001-01-03 Use of enoxaparin for the treatment of cerebral ischemia DK1248638T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000137A FR2803522B1 (en) 2000-01-06 2000-01-06 NEW THERAPEUTIC APPLICATION OF ENOXAPARIN
PCT/FR2001/000014 WO2001049298A2 (en) 2000-01-06 2001-01-03 Novel therapeutic use of enoxaparin

Publications (1)

Publication Number Publication Date
DK1248638T3 true DK1248638T3 (en) 2007-03-19

Family

ID=8845669

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01903859T DK1248638T3 (en) 2000-01-06 2001-01-03 Use of enoxaparin for the treatment of cerebral ischemia

Country Status (30)

Country Link
EP (1) EP1248638B1 (en)
JP (1) JP2003519185A (en)
KR (1) KR20020069240A (en)
CN (1) CN1400905A (en)
AR (1) AR026804A1 (en)
AT (1) ATE344671T1 (en)
AU (1) AU784656B2 (en)
BR (1) BR0107442A (en)
CA (1) CA2396178A1 (en)
CZ (1) CZ20022303A3 (en)
DE (1) DE60124373T2 (en)
DK (1) DK1248638T3 (en)
EA (1) EA006035B1 (en)
EE (1) EE200200374A (en)
ES (1) ES2275648T3 (en)
FR (1) FR2803522B1 (en)
HK (1) HK1052649A1 (en)
HR (1) HRP20020573A2 (en)
HU (1) HUP0204040A3 (en)
IL (1) IL150477A0 (en)
MX (1) MXPA02006672A (en)
NO (1) NO20023243D0 (en)
NZ (1) NZ520283A (en)
PL (1) PL357192A1 (en)
PT (1) PT1248638E (en)
SK (1) SK9612002A3 (en)
UA (1) UA75587C2 (en)
WO (1) WO2001049298A2 (en)
YU (1) YU51802A (en)
ZA (1) ZA200205415B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007003121A1 (en) * 2006-10-30 2008-05-16 Aventis Pharma Sa USE OF A DOSE OF 40 MG OF SODIUM ENOXAPARINE AS A MINIMUM TO TREAT A PATIENT 65 YEARS OF AGE OR OLDER WITH ACUTE ISCHEMICAL ICTUS OR A MEDIUM SCORE OF 10 OR HIGHER ON THE NIH SCALE FOR ICTUS.
ITMI20091445A1 (en) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico SEMI-SYNTHETIC DERIVATIVES OF K5 POLISACCARIDE FOR THE PREVENTION AND TREATMENT OF TISSUE DAMAGE ASSOCIATED WITH ISCHEMIA AND / OR REPERFUSION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008595A1 (en) * 1992-10-13 1994-04-28 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics

Also Published As

Publication number Publication date
IL150477A0 (en) 2002-12-01
NZ520283A (en) 2004-09-24
DE60124373D1 (en) 2006-12-21
HK1052649A1 (en) 2003-09-26
KR20020069240A (en) 2002-08-29
FR2803522A1 (en) 2001-07-13
ATE344671T1 (en) 2006-11-15
JP2003519185A (en) 2003-06-17
HRP20020573A2 (en) 2003-10-31
HUP0204040A3 (en) 2003-05-28
CA2396178A1 (en) 2001-07-12
PL357192A1 (en) 2004-07-26
CZ20022303A3 (en) 2002-11-13
NO20023243L (en) 2002-07-04
WO2001049298A3 (en) 2002-04-04
CN1400905A (en) 2003-03-05
EA200200750A1 (en) 2003-02-27
HUP0204040A2 (en) 2003-04-28
DE60124373T2 (en) 2007-08-30
ES2275648T3 (en) 2007-06-16
ZA200205415B (en) 2003-10-13
EP1248638B1 (en) 2006-11-08
MXPA02006672A (en) 2002-09-30
BR0107442A (en) 2002-10-08
UA75587C2 (en) 2006-05-15
YU51802A (en) 2005-06-10
AU3183001A (en) 2001-07-16
FR2803522B1 (en) 2004-01-02
SK9612002A3 (en) 2002-12-03
NO20023243D0 (en) 2002-07-04
EP1248638A2 (en) 2002-10-16
WO2001049298A2 (en) 2001-07-12
AU784656B2 (en) 2006-05-18
PT1248638E (en) 2007-02-28
AR026804A1 (en) 2003-02-26
EE200200374A (en) 2003-12-15
EA006035B1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
DK1259512T3 (en) Pteridine compounds for the treatment of psoreasis
DK1343773T3 (en) Thiazole derivatives for the treatment of PPAR-related disorders
EE200200172A (en) Compounds for the treatment of ischemia
DE60130381D1 (en) mother leadership
DK1575597T3 (en) Use of rimexolone for the treatment of eye dryness
DK1292594T3 (en) Quinazoline derivatives for the treatment of tumors
DK1803718T3 (en) 4-Tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
DK1499730T3 (en) Immunoconjugates for the treatment of tumors
DK1448205T3 (en) Combinations for the treatment of immuno-inflammatory diseases
DE50200641D1 (en) locking device
DK1411917T3 (en) Carbamate compounds for use in the prevention or treatment of movement disorders
DK1392318T3 (en) 15-keto-prostaglandins for the treatment of drug-induced constipation
DK1324970T3 (en) Retinoids for the treatment of emphysema
DK1176964T3 (en) Use of ET743 for the treatment of cancer
DK2189162T3 (en) Methods for the treatment of cellular proliferative disorders
DK1345598T3 (en) The use of rosiglitazone in the treatment of psychiatric disorders
DK1344526T3 (en) Means for the prevention / treatment of inflammatory respiratory disorders
DE60112580D1 (en) locking device
DK1401424T3 (en) Carbamate compounds for use in the prevention or treatment of psychotic disorders
PT1220858E (en) OXAZINOQUINOLONES UTEIS FOR THE TREATMENT OF VIRAL INFECTIONS
DK1257278T3 (en) Use of mirtazapine for the treatment of sleep disorders
PT1268482E (en) PIRANOINDOIS FOR THE TREATMENT OF GLAUCOMA
DK1248638T3 (en) Use of enoxaparin for the treatment of cerebral ischemia
DK1468686T3 (en) S-methyl-dihydro-ziprasidone for the treatment of psychiatric disorders
IS6626A (en) Crystalline treatment agent